Venclyxto Den Europæiske Union - kroatisk - EMA (European Medicines Agency)

venclyxto

abbvie deutschland gmbh co. kg - venetoclax - leukemija, limfocitna, kronična, b-stanica - antineoplastična sredstva - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly  diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.

Calquence Den Europæiske Union - kroatisk - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - leukemija, limfocitna, kronična, b-stanica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Imbruvica Den Europæiske Union - kroatisk - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Brukinsa Den Europæiske Union - kroatisk - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

LINCOCIN 40% Kroatien - kroatisk - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

lincocin 40%

zoetis netherlands holdings b.v. podružnica zagreb za promidžbu, petra hektorovića 2, zagreb, hrvatska - linkomicin - prašak za pripremu peroralne otopine - svinja i tovnih pilića

MACROPEN 400 mg/1 tableta filmom obložena tableta Bosnien-Hercegovina - kroatisk - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

macropen 400 mg/1 tableta filmom obložena tableta

krka farma d.o.o. sarajevo - midekamicin - filmom obložena tableta - 400 mg/1 tableta - 1 filmom obložena tableta sadrži: 400 mg midekamicina

MACROPEN 175 mg/5 mL granule za oralnu suspenziju Bosnien-Hercegovina - kroatisk - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

macropen 175 mg/5 ml granule za oralnu suspenziju

krka farma d.o.o. sarajevo - miokamicin - granule za oralnu suspenziju - 175 mg/5 ml - 5 ml oralne suspenzije sadrži: 175 mg miokamicina

MACROPEN 400 mg/1 tableta filmom obložena tableta Bosnien-Hercegovina - kroatisk - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

macropen 400 mg/1 tableta filmom obložena tableta

krka farma d.o.o. sarajevo - midekamicin - filmom obložena tableta - 400 mg/1 tableta - 1 filmom obložena tableta sadrži: 400 mg midekamicina

MACROPEN 175 mg/5 mL granule za oralnu suspenziju Bosnien-Hercegovina - kroatisk - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

macropen 175 mg/5 ml granule za oralnu suspenziju

krka farma d.o.o. sarajevo - miokamicin - granule za oralnu suspenziju - 175 mg/5 ml - 5 ml oralne suspenzije sadrži: 175 mg miokamicina (midekamicinacetata)

Bendamustin Kabi 2,5 mg/ml prašak za koncentrat za otopinu za infuziju Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

bendamustin kabi 2,5 mg/ml prašak za koncentrat za otopinu za infuziju

fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - bendamustinklorid - prašak za koncentrat za otopinu za infuziju - 2,5 mg/ml - urbroj: jedna bočica sadrži 25 mg bendamustinklorida; jedna bočica sadrži 100 mg bendamustinklorida; nakon rekonstitucije 1 ml koncentrata sadrži 2,5 mg bendamustinklorida